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ABSTRACT 
Molecular Modulation of α-Subunit VISIT-DG Sequence Residue Asp-350 in the Catalytic sites 
of Escherichia coli ATP Synthase 
by 
Sneha Reddy Jonnalagadda 
ATP Synthase is the fundamental means of cellular energy production in animals, plants, and 
almost all microorganisms. In order to understand the mechanism of ATP catalysis, critical 
amino acid residues involved in Pi binding have to be identified. The αVISIT-DG sequence at 
the interface of α/β subunits that contains residues from 345-351 is highly conserved and αAsp-
350 has been chosen because of its negative charge side chain and its close proximity (~2.8 Å) to 
the known phosphate binding residue αArg-376. The mutant’s αD350R, αD350Q, αD350A, 
αR376A/D, and αG351R/A/D were generated by site directed mutagenesis and several 
biochemical assays were performed on them to understand the role played by the amino acid 
residues in Pi binding. Biochemical results suggest that αD350 may be involved in catalysis of 
ATP synthase and play an important role in Pi binding, whereas αG351 may be involved only in 
the structural integrity.  
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CHAPTER 1 
 
INTRODUCTION 
 
ATP synthase, also known as F1Fo –ATPase, is the fundamental means of energy 
production that catalyzes the synthesis of ATP during oxidative phosphorylation or 
photophosphorylation. The enzyme is capable of hydrolyzing and synthesizing ATP in a 
reversible reaction. The enzyme was discovered in 1929 by Karl Lohmann, and in 1935 Vladimir 
Engelhart noted that muscle contractions require ATP. Fritz Lipmann demonstrated that ATP is 
the main bearer of chemical energy in the cell in 1941, and Alexander Todd synthesised ATP 
chemically in 1948.  Slater proposed a scheme showing the chemical intermediates to explain the 
mechanism of oxidative phosphorylation [1]. Coupled oxidative phosphorylation was shown to 
be activated by a soluble factor in bacteria particulate [2]. Soluble adenosine triphosphatase was 
then shown to participate in oxidative phosphorylation [3]. The chemiosmotic hypothesis 
postulated the primary role of membranes that separate 2 compartments and therefore maintains 
a gradient of proton activity, generated by respiration chain enzymes, that was used by ATP 
synthase [4]. On the basis of the kinetics of enzyme-catalysed 18O exchange between H2O and 
Pi/ATP, a binding change mechanism was proposed. The binding change mechanism involves 
the active site of a β subunit cycling between three states. In the "open" state, ADP and 
phosphate enters the active site where the protein then closes up around the molecules and binds 
them loosely. The enzyme then undergoes another change in shape and forces these molecules 
together, with the active site in the resulting tight state binding the newly-produced ATP 
molecule with very high affinity.  The active site then cycles back to the open state, releasing 
10 
 
ATP and binding more ADP and phosphate, ready for the next cycle of ATP production. The F1 
catalytic domain of ATP synthase was crystallized, which essentially supported the hypothesis 
that Boyer’s binding change mechanism was correct. 
 In view of the fact that ATP synthase uses ATP to drive proton gradient for transport 
purposes, it is highly conserved in all organisms. In Escherichia coli, ATP synthase has 2 major 
components (F1 and Fo) and 8 different subunits (α3, β3, γ, δ, ε, a, b, c10-15). The water soluble F1 
sector is made up of 3α subunits, 3β subunits and one each of γ, δ, and ε subunits. The membrane 
embedded Fo sector consists of 1a, 2b and 10-15c subunits [Fig 1]. The overall molecular mass 
of the complex is ~530KDa. 
ATP synthase has 3 catalytic sites located on the α/β interface.  Proton pumping occurs 
through membrane embedded F0 sector [5, 6]. The F1 subunit is part of the “rotor” that is composed 
of γ,ε, and a ring of c subunits. The γ-subunit is comprised of three α-helices. 2 of these helices 
form a coiled coil that go right up into the central space of the α3ß3 hexagon. The “stator” is 
composed of 2 b and δ subunits.  The function of the stator is to prevent co-rotation of catalytic 
sites and the ‘a’ subunit with the rotor [7, 8]. Proton gradient-driven clockwise rotation of γ (as 
viewed from the membrane) leads to ATP synthesis and anticlockwise rotation of γ results in 
ATP hydrolysis. ATP synthase works like a motor and in fact it is the smallest known biological 
nanomotor. Detailed reviews of ATP syntheses structure and function may be found in 
references [9-16].  
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Figure 1: The Rotary Mechanism of ATP Synthase. (Reproduced from [42] with permission; 
copyright Elsevier).The enzyme consists of 2 sectors catalytic F1 and membrane bound Fo. F1 
consists of α3, β3, γ, δ, and ε. Fo consists of ab2c10. In mitochondria and chloroplasts additional 
subunits are present. The rotor stalk indicates the helical coiled-coil extension of the γ subunit 
into the central cavity of the α3/ β3 hexagon. The rotor is composed of γ, δ, and a ring of c 
subunits. The “stator” is composed of b2δ. The proton pathway lies between ‘a’ and ‘c’ subunits. 
[39]  
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Determining the Reaction Mechanism of ATP Synthase 
In order to understand the reaction mechanism of ATP synthesis and hydrolysis and their 
relationship to rotation in this biological nanomotor, our lab has focused mainly on 
• Understanding the role of conserved residues in and around catalytic site Pi-binding 
sub-domain [22].  
• Modulating the catalytic site for improved catalytic and motor function of the 
enzyme.  
• Understanding the relationship between Pi binding and subunit rotation [20-22]. 
• How ATP synthase binds ADP and Pi within its catalytic sites in the face of relatively 
high ATP/ADP concentration ratio. 
 
Importance of VISIT-DG 
 The α-subunit Valine, Isoleucine, Serine, Isoleucine, Threonine, Aspartate, Glycine 
(VISIT-DG) [Fig 2] residues are highly conserved throughout all living organisms. Earlier αArg-
376, βArg-182, βLys-155, and βArg-246 were shown to be involved in Pi binding [20, 22]. 
Recently αSer-347 of VISIT-DG sequence was also indentified as a fifth Pi binding residue [22, 
Fig 3]. Generally, the other VISIT-DG sequence residues are of special interest and in particular, 
αAsp-350 is of special interest due to its negative charge. This residue is also in close proximity 
(~2Å) to αArg-376, a known Pi binding residue.  Here, we would like to investigate the role of 
αAsp-350 in direct/ indirect Pi binding and or in the maintenance of the Pi binding subdomain. 
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Figure 2: Amino Acid Sequence Alignment of Evolutionarily Conserved α-subunit VISIT-DG 
Sequence. (Adapted from [22] with permission from ASBMB, 2009) α- subunit sequence from 
different species is aligned. The highly conserved VISIT-DG sequence is highlighted in gray. 
The starting residue arginine shown here for E. coli is αR300. [22] 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: X-Ray Crystal Structure of Catalytic Sites in the α-subunit of Mitochondrial ATP 
Synthase. (Adapted from [22] with permission from ASBMB, 2009) The triangle showing the 
residues βR182, βK155, αR376, βR246, αS347 together form a catalytic triad. αD350 is of 
special interest due to its close proximity (~2Ao) to a known Pi binding residue αR376.Residues 
in the boxes define the VISIT-DG. [22] 
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Inhibition of ATP Synthase 
 
                  7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl) is a potent inhibitor of ATP 
synthase. It provides a measure of the Pi binding. NBD-Cl reacts with the phenolic oxygen of 
Tyr-311 of the βE subunit that contains no bound nucleotide. The 2 other catalytic subunits βTP 
and βDP contain bound adenylyl-imidodiphosphate (AMP-PNP) and ADP respectively. The 
binding site of the NBD moiety doesn’t overlap with the regions of βE that form the nucleotide 
binding pocket in subunits βTP and βDP, nor does it occlude the nucleotide-binding site. 
Catalysis appears to be inhibited because neither βTP nor βDP can accommodate a Tyr-311 
residue bearing a NBD group. NBD-Cl inhibits the enzyme by preventing the modified subunit 
from adopting a confirmation that is essential for catalysis to proceed. NBD-Cl forms a covalent 
adducts with βTyr-297 in E.coli at a stoichiometry of 1mol/mol and inhibits F1 ATPase activity 
[17]. NBD-Cl reacts only in the empty (βE) catalytic site, and it doesn’t act as a nucleotide 
analog based on the location of the derivatized Tyr residue in the X-ray structure.  
This was supported by the 2 lines of evidence. Pseudo-first order rate constant for 
inhibition (KObs) was linearly dependent upon NBD-Cl concentration, implying that no initial 
binding event was required. Secondly, MgADP protected purified F1 and F1Fo in membrane from 
reaction with NBD-Cl, but only at extremely high concentration that would effectively keep the 
third site (βE) occupied in time average and thus impede access by NBD-Cl by closing the site 
[17]. Eventually Perez et al. [18] reported that Pi protection against NBD-Cl inhibition of 
ATPase activity of ATP synthase in mitochondrial membrane preparations, potentially a tool to 
assay Pi binding in βE catalytic site. This was applicable to both membrane bound enzyme and 
with purified F1 from E. coli [9].  Several inhibitory studies were performed using transition state 
analogs. The transition state analog MgADP-AlF4- trapped in catalytic sites has been visualized 
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by x-ray crystallography [19], and it is clear that the fluoroaluminate group occupies the position 
of phosphate in the transition state complex can be compared by assay of inhibition of ATPase 
activity by MgADP-fluoroaluminate (MgADP-fluoroscandium) in mutant and wild-type 
enzymes [20, 21]. 
 
Hypotheses 
• The highly conserved α-subunit VISIT-DG sequence residue Asp-350 is directly or 
indirectly involved in phosphate binding through αArg-376. 
• αAsp-350 is important for function through its role in maintaining the structural integrity 
of the Pi binding subdomain and not involved in Pi binding per se. 
• The carboxyl side chain of αAsp-350 may be involved in establishing transition state. 
• The compensatory effect of αD350 can be determined through αD350R/αR376A and 
repulsive effect through αD350/αR376D [13]. This can help in exploring the role of 
αD350 in Pi binding and/or structural integrity. 
The aspartate and glycine residues of VISIT –DG sequence have been replaced by 
various other amino acids such as arginine, glutamine, alanine, etc through site directed 
mutagenesis.  Left and right oligonucleotides were designed with the desired mutations. The 
single stranded template DNA was amplified in PCR using DNA polymerase and primers. These 
plasmids, thus obtained, were then transformed into the DK8 strain that lacks ATP synthase 
gene. The plasmids isolated from DK8 were then sent to sequencing to confirm the presence of 
desired mutations. Once the desired mutants are obtained, several inhibitory studies were carried 
on the membranes of different mutants. These inhibitory studies enable us to understand the role 
played by different residues in phosphate binding. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
Chemicals 
Adenosine 5-triphosphatase disodium salt, ampicillin, glucose, succinic acid, uracil, 
TES, TRIZMA (Tris[Hydroxyethyl] ethane), 4-aminobenzamidine dihydrchloride (PAB), SDS 
(Sodium dodecyl sulfate), Isopropyl β-D-1-thiogalactopyranoside (IPTG), 5-bromo-4-chloro-3-
indolyl- beta-D-galactopyranoside (X-Gal), βmercaptoethanol, agarose, adenosine 5’-
diphosphate (ADP), 4-chloro-7-nitrobenzofurazan (NBD-Cl) , N,N'-dicyclohexylcarbodiimide 
(DCCD), dithiothreitol (DTT), sodium fluoride (NaF), aluminum chloride(AlCl3), and scandium 
chloride(SnCl3) were purchased from Sigma–Aldrich Chemical Company. 
 
Buffers and Reagents 
50mM Tris-H2SO4 (pH-8), ATPase assay buffer, T&S reagent (Taussky and Shorr 
reagent), 10%SDS, TE(trace elements), 1M MgSO4, AET (Arginine Ent Thiamine), 
ILV(isoleucin-valine), STEM, TES 50, and TES5 +PAB, 10x reaction buffer, dNTP mix, quick 
solution reagent, cell resuspension solution, column wash solution, and neutralization solution 
were prepared as described in Appendix B.  
 
Culture Media 
LB medium, minimal media, limiting glucose, succinate media, NZY broth, XL ultra 
competent cells, and culture media (liquid and plates) were prepared as described in Appendix C. 
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All other standard chemicals used in this study were ultra pure analytical grade purchased either 
from Sigma-Aldrich Chemical Company or Fisher Scientific Company. 
 
Equipment 
Table top centrifuge (Thermo Scientific), Polymerase chain reactor, Gel doc, Stasar III 
Colorimeter (Gilford, Oberlin, OH) Evolution-300 UV-Visible Spectrophotometer (Thermo 
Scientific, Pittsford, NY), French press, cell disrupter (Thermo Scientific, Asheville, NC), C76 
Water Bath shaker (New Brunswick Scientific Co. inc, Edison, NJ ), Sorvall WX ultra 80, Ultra 
Centrifuge (Thermo Scientific, Asheville, NC), Sorvall RC-5Bsuper speed Centrifuge (Thermo 
Scientific, Asheville, NC), Series 25, and incubator shaker (New Brunswick Scientific Co. inc, 
Edison, NJ ) were used during experiments. 
 
Designing the Primers 
The mutagenic primers must contain the desired mutations and anneal to the same 
sequence on the opposite strand of the plasmid. The primers were designed with a minimum GC 
content of 40% and approximately of 25 to 45 bases in length with a Tm>78°C. The desired 
mutation was in the middle of the primer with ~10-15 bases of correct sequence on both sides. 
 
Site-Directed Mutagenesis 
 Mutagenesis was performed using Quick-change site directed mutagenesis kit [26]. In 
site directed mutagenesis a super coiled double stranded DNA vector (M13mp18) with an insert 
of interest (α-subunit of E. coli ATP synthase) has been used. The left and right oligonucleotides 
were synthesized with the desired mutation and were used during reaction. The left and right 
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primers, each complementary to the vector, are extended in a polymerase chain reaction by DNA 
polymerase. Thus, the mutant plasmids with the nicks were generated. These nicks were cleaved 
by DpnI endonucleases and the nicked mutated plasmid DNA was transformed into XL1-
supercompetent cells. The plasmids from these mutants were isolated and transformed into DK8 
strains that lack ATP synthase gene. The reaction procedure is described as below. 
The control reaction was prepared using 10x Reaction buffer, 10ng of pBW4.5kb control 
plasmid (5ng/µl), 125ng of oligo control primer1 [34mer (100ng/µl)], 125ng of oligo control 
primer2 [34mer (100ng/µl)], 1µl of dNTP mix, and 3µl of quick solution reagent. The final 
volume was made to 50µl using water. The sample reaction was prepared using 5µl of 10x 
reaction buffer, 10-100ng of dsDNA template, 125ng of oligo primer1, 125ng of oligo primer2, 
1µl of dNTP mix, and 3µl of quick solution reagent. Final volume was made to 50µl using water. 
1µl (2.5U/µl) of quick change lightning enzyme (DNA polymerase) was added to each of the 
control and sample reactions. The cycling parameters for PCR are shown in Table 1. 
Table1: Cycling Parameters for the Polymerase Chain Reaction 
Segment Cycle Temperature Time 
1 1 95°C 2min 
2 18 95°C, 60°C, 68°C 20sec,10sec,30sec/kb 
3 1 68°C 5min 
 
Once the PCR was done, DpnI restriction enzyme was added to each of the vials [26]. 
The reactions were incubated for 1 hour to digest the parental (i.e: the nonmutated) super coiled 
dsDNA. In order to transform, XL10 ultra competent cells were used. 45µl of ultra competent 
cells were aliquoted and mixed with 2µl of βmercaptoethanol to improve transformation 
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efficiencies. The mixture was incubated on ice for 10 minutes. 2µl of DpnI treated DNA from 
control and sample reactions were transferred into separate aliquots of ultra competent cells and 
incubated on ice for 30 minutes. The tubes were given heat pulse for about 30 seconds and 
immediately placed on ice for 2 minutes. 0.5ml of NZY broth was added to each tube and 
allowed it to incubate at 37°C for 1 hour with shaking at 225-250 rpm. Cells were spread on LB-
AMP agar plates containing 80µg/µl X-Gal and 20mM IPTG, and the plates were incubated at 
37°C for more than 16 hrs. Once the positive colonies were observed, they are picked and grown 
in LB-AMP broth for 6-8 hrs. The plasmids were isolated using Promega mini prep kit.  
 
Plasmid Isolation   
10ml (low-copy-number plasmid) of bacterial culture was harvested by centrifugation for 
5 minutes at 10,000 x g in a tabletop centrifuge. The supernatant was discarded and the tubes 
were inverted to remove the excess media. 250µl of cell resuspension solution was added, and 
the cell pellet was thoroughly resuspended by pipetting.  250µl of cell lysis solution was added, 
and mixed by inverting the tube 4 times. The tubes were incubated for 1-5minutes until the cell 
suspension is cleared. 10µl of alkaline protease solution was added and mixed by inverting the 
tubes 4 times and were incubated for 5 minutes at room temperature. Alkaline protease 
inactivates endonucleases and other proteins released during the lysis of the bacterial cells that 
can adversely affect the quality of the isolated DNA. The incubation should not exceed for more 
than 5 minutes with alkaline protease solution, as nicking of the plasmid DNA may occur. 350µl 
of neutralization solution was added and mixed immediately by inverting the tubes 4 times. The 
lysate was centrifuged at maximum speed (around 14,000 × g) in a micro centrifuge for 10 
minutes at room temperature. The cleared lysate was transferred to the spin column by decanting. 
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The supernatant was centrifuged at maximum speed in a micro centrifuge for 1 minute at room 
temperature and the spin column was removed from the tube, and flow through was discarded 
from the collection tube. To the spin column, 750µl of column wash solution was added and 
centrifuged at maximum speed for 1 minute. The supernatant was discarded and again washed 
with column wash solution by centrifuging at maximum speed for 1minute. The spin column was 
transferred to a new, sterile 1.5ml micro centrifuge tube.100µl of nuclease-free water was added 
to the spin column and centrifuged to elute the plasmid DNA. Plasmid DNA was stored at –20°C 
or below in water. 
 Once the plasmids were isolated, restriction digestion was performed with specific 
enzymes for each mutation. The bands were observed on 1% agarose gel electrophoresis using 
standard protocol. Once the bands of required length are obtained, the plasmids were sent to 
sequencing. Sequencing results confirmed the presence of mutation and the plasmids with the 
desired mutation were again transformed into DK8 strain using electroporation method [23, 24]. 
The mutants were thus obtained and can be used for further experiments. 
 
Growth Yield on Succinate and in Limiting Glucose [28] 
The colonies of each mutant strain were streaked on to succinate plates and were 
observed for 3 days. The mutant strains were inoculated into limiting glucose and allowed to 
grow at 37°C, 250 rpm in water bath. The O.D was observed at 595nm for every hour till late log 
phase. This determines the amount of the membrane to be used and time of incubation. 
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Preparation of E. coli Membrane Bound ATP Synthase [27] 
Starter Culture 
Minimal media was prepared in one large batch and distributed into 250ml flasks with 
50ml each for better aeration. Necessary additions were made and the flasks were inoculated 
with 10-15ml LB-AMP broth that has been previously grown overnight (16-20hrs) at 37°C, 250 
rpm and allowed to grow for 6-8 hrs in 37°C water/air shaker at 250 rpm. These were used as 
inoculums for 1litre flasks. 
 
Bacterial Growth 
50ml of overnight starter cultures were inoculated into 1litre minimal media and grown at 
37°C, 250 rpm. Growth yield was measured at O.D595 every hour till late log phase. Once the late 
log phase was obtained, the cells were harvested. 
 
Harvesting the Cells 
The cells were harvested by spinning the culture at 2°C in a Sorvall RC-5B refrigerated 
Super speed centrifuge at 9500 rpm for 15 min. The harvested sample was resuspended in STEM 
and centrifuged at 9500 rpm for 25 min. The supernatant was discarded and the pellet is 
resuspended in 2 ml STEM/g wet cells and was stored at -80°C overnight. 
 
Membrane Bound ATP Synthase Isolation 
Cells from overnight were thawed and mixed with DNAse to digest nucleic acids. The 
cells were then disrupted by 2 passages through chilled French press cell fractionator at 2000 psi. 
Cell debris was pelleted by centrifugation at 18K rpm for 20 min using Sorvall WX ultra-80, 
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Ultra Centrifuge. Subsequently, the membranes were pelleted by spinning the supernatant at 60K 
rpm for 120 min. The membrane was then resuspended in TES 50 and centrifuged at 60K rpm 
for 120 min. The pellet was then washed with TES 5 + PAB by spinning twice at 60K rpm for 90 
min. Finally the purified membrane was resuspended in 50mM Tris Sulfate (pH 8), 2.5mM 
MgSO4 and stored at -80°C. 
 
Membrane Concentration and ATPase Assay 
Membrane concentrations were found by plotting the absorbance at 595nm using 
Bradford reagent against standard BSA curve. Amount of membrane and time of incubation 
depends on growth assays and vary with each preparation. ATPase activity was measured by 
adding 1 ml of assay buffer containing 10mM NaATP, 4mM MgCl2, 50mM TrisSO4(pH 8) to 
the purified F1 or membranes at 37°C and stopped by addition of SDS to 3.3% final 
concentration. Pi release was assayed by adding 1 ml of T&S reagent containing 10mM 
(NH4)6Mo7O24·4H2O , 250mM Fe(NH4)2(SO4)2·6H2O, and 1.176 N H2SO4 [29]. The color 
that developed was measured using a Stasar III Colorimeter at 700 nm. A graph is plotted using 
Sigma plot software with activity on X-axis and OD700 on Y-axis. There is a straight line 
relationship between the calorimetric reading and the concentration of phosphate. The reaction 
is: 
 
ATP + ATP Synthase                 ADP + Pi 
Pi + T&S                                        Blue color measured at O.D700 
Specific Activity= (Sample O.D- Blank O.D) / [Amount (mg)*Time (min)] 
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Inhibition of ATPase Activity by NBD-Cl 
The three catalytic sites located on the F1 sector of ATPase are βTP, βDP, βE. Pi are 
supposed to bind in the βE site for ATP synthesis. Fortuitously, NBD-Cl reacts specifically in the 
βE site thus preventing the ATP synthesis [17]. NBD-Cl reacts with NBD-Cl was prepared as a 
stock solution in dimethyl sulfoxide and protected from light. The membranes were reacted with 
different concentrations of NBD-Cl for 60min in dark at room temperature in 50mM Tris-SO4 
(pH 8), 2.5mM MgSO4. Then, 1ml of ATPase assay buffer was added into the tubes and allowed 
to incubate at varied times for different mutants. The reaction was stopped by 10%SDS and 
ATPase activity was determined after adding T&S at O.D700 
• 50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + ATPcktl + 10% SDS +T&S (2-5 min) 
• 50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + 10% SDS +T&S (2-5 min) 
 
Extra Pulse of NBD-Cl 
It was mainly performed to see whether the maximal reaction with NBD-Cl occurred or 
not. The membrane was incubated in dark with 150µM NBD-Cl for 60min at room temperature 
in 50mM Tris-SO4, 2.5mM MgSO4, and then, an extra pulse of 200µM NBD-Cl was added and 
incubated for another 60min. Then, 1ml of ATPase assay buffer was added into the tubes and 
allowed to incubate at varied timings for different mutants. The reaction was stopped by 
10%SDS and ATPase activity was determined after adding T&S at O.D700 
• 50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + 200µM NBD-Cl (inc 1h) + ATPcktl + 10% 
SDS +T&S (2-5 min). 
• 50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + 200µM NBD-Cl (inc 1h) + 10% SDS + 
ATPcktl + T&S (2-5 min). 
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DTT Reversibility 
NBD-Cl inhibition was reversed by incubating the membranes with DTT for 60min at 
room temperature.  NBD-Cl incubations are performed in the dark where as DTT should be 
maintained cool. The control samples without NBD-Cl and/or DTT were incubated for the same times. 
Then, 1ml of ATPase assay buffer was added into the tubes and allowed to incubate at varied 
timings for different mutants. The reaction was stopped by 10%SDS and ATPase activity was 
determined after adding T&S at O.D700. 
• 50mM T8 + Mbr + ATPcktl + 10% SDS + T&S (2-5 min) 
• 50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + ATPcktl + 10% SDS + T&S (2-5 min) 
• 50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + 4mM DTT (inc 1h) + ATPcktl + 10% SDS 
+ T&S (2-5 min) 
• 50mM T8 + Mbr + 4mM DTT (inc 1h) + ATPcktl + 10% SDS + T&S (2-5 min) 
 
Mg Pi Protection Against NBD-Cl 
The membranes were preincubated for 60min with Pi and an equimolar Mg+2 at room 
temperature in 50mM Tris-SO4, 2.5mM MgSO4. The concentration of Pi ranged from 25mM to 
100mM. 150µM NBD-Cl was added to the above tubes and incubated at room temperature in the 
dark for 60min.The control contained the protecting agent without NBD-Cl. Then, 1ml of 
ATPase assay buffer was added into the tubes and allowed to incubate at varied timings for 
different mutants. The reaction was stopped by 10%SDS and ATPase activity was determined 
after adding T&S at O.D700 
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MgADP Protection Against NBD-Cl   
The membrane was incubated with MgADP with varied concentrations ranging from 0-
12mM before adding NBD-Cl. The concentrations of Mg and ADP should be in 1:1 ratio. Then, 
150µM NBD-Cl was added to it and incubated at room temp in the dark for 60min. The control 
contained MgADP without NBD-Cl and MgADP alone has no inhibitory effect. Then, 1ml of 
ATPase assay buffer was added into the tubes and allowed to incubate at varied timings for 
different mutants. The reaction was stopped by 10%SDS and ATPase activity was determined 
after adding T&S at O.D700 
 
Inhibition of ATPase Activity by Transition State Analogs 
The membranes were incubated for 60 min at room temperature in 50mM TrisSO4, 
2.5mM MgSO4, 1mM NaADP, and 10mM NaF at a protein concentration of 0.2–0.5 mg/ml in 
presence of AlCl3 or ScCl3 added at varied concentrations. 50µl aliquots were then added to 1 ml 
of ATPase assay buffer, and activity was measured at O.D700. It was confirmed in control 
experiments that no inhibition was seen if MgSO4, NaADP, or NaF was omitted. 
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CHAPTER 3 
 
RESULTS 
Designing the Mutations and the Enzymes Used to Identify the Mutation 
The site directed mutagenesis was performed and the mutants were obtained. The αAsp-
350 was mutated to Arginine(R), Glutamine (Q), and Alanine (A). The αArg-376 was mutated to 
Alanine (A) and Glutamate (D) and the αGly-351 to Arginine (R). The double mutants were also 
generated to see the repulsive and compensatory effects.  The enzymes shown in the Table 2 are 
used in the restriction digestion of the mutated site. DNA sequencing results confirmed the 
presence or absence of the mutations. 
Table 2: Table Representing the Name, Mutated Site, and Enzymes 
Name and Mutated site Mutation Enzyme 
pSR1 (αD350R) GAT(D)→CGT(R) PmlI 
pSR2 (αD350Q) GAT(D)→CAG(Q) DdeI 
pSR3 (αD350A) GAT(D)→GCG(A) SacII 
pSR4 (αR376A) CGT(R)→GCC(A) EagI 
pSR5 (αG351R) GGT(G)→CGT(R) PvuI 
pSR6 (αR376D) CGT(R)→GAC(D) AatII 
pSR7 (αD350R/ αR376A) GAT→CGT/CGT→GCC PmlI-EagI 
pSR8 (αD350R/ αR376D) GAT→CGT/CGT→GAC PmlI-AatII 
pSR9 (αG351R/ αR376A) GGT→CGT/CGT→GCC PvuI-EagI 
pSR10 (αG351R/ αR376D) GGT→CGT/CGT→GAC PvuI-AatII 
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Growth Yield on Succinate and in Limiting Glucose  
A series of mutants were generated. The residue aspartate was chosen for mutagenesis 
because of its strong conservation in the α-subunit VISIT-DG sequence and its close proximity 
to the Pi binding pocket. αR376, which is a known Pi binding residue, was also modulated. 
αD350R /αR376A/D were designed to test the compensatory effect and αD350/αR376D was 
designed to test the repulsive effect. Table 3 shows that the introduction of arginine and alanine 
in αD350 and alanine in αR376 resulted in loss of oxidative phosphorylation. Growth yields 
were very close to null control where as all the double mutants showed partial loss of oxidative 
phosphorylation. ATPase activities of αD350R, αD350A, αR376A, αG351R are very low when 
compared to the wild type. However αD350R/αR376A did restore ATPase activity significantly, 
but the rest of the double mutants are still showing low ATPase activities. 
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Table 3: Effects of αD350 and αR376 Mutations on Cell Growth and ATPase Activity 
Mutation a Growth on Succinate b Growth Yield in 
Limiting glucose (%) 
ATPase Activity c 
(µmol/min/mg) 
Wild type ++++ 100 11.28 
Null - 52.69 0 
(αD350R) +/- 55 .03 
(αD350Q) ++++ 65 2.19 
(αD350A) +/- 49 .07 
(αR376A) +/- 56 .06 
(αG351R) +/- 58 .03 
(αR376D) +++ 56 .19 
(αD350R/ αR376A) ++ 73 .46 
(αD350R/ αR376D) +++ 68 .04 
(αG351R/ αR376A) +++ 61.98 .04 
(αG351R/ αR376D) +++ 68 .03 
a Wild type, pBWU13.4/DK8; Null, PUC118/DK8; 
b Growth on succinate plates after 3 days estimated by eye. ++++, heavy growth; +, partial 
growth; +/-, very low growth; -, no growth 
c ATPase activity was measured at 37°C and expressed as µmol of ATP hydrolyzed/ min/ mg of 
membrane protein. 
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Inhibition of ATPase Activity of ATP Synthase by NBD-Cl 
NBD-Cl reacts with the phenolic oxygen of Tyr-311 of the βE subunit that contains no 
bound nucleotide. The 2 other catalytic subunits βTP and βDP contain bound adenylyl-
imidodiphosphate (AMP-PNP) and ADP respectively. The binding site of the NBD moiety 
doesn’t overlap with the regions of βE that form the nucleotide binding pocket in subunits βTP 
and βDP, nor does it occlude the nucleotide-binding site. Catalysis appears to be inhibited 
because neither βTP nor βDP can accommodate a Tyr-311 residue bearing a NBD group [17].  
The NBD-Cl inhibition of each mutant with respect to wild type is shown in Figure 4. 
Wild type ATP synthase enzyme is shows 100% inhibition, whereas all the newly generated 
mutants aren’t. The αD350Q was almost completely inhibited just like wild type whereas 
αD350R, αR376D, αD350R/ αR376A, mutants are showing ~80-90% inhibition with 10-20% 
residual activity. αD350A, αR376A, αG351R/αR376A, αG351R/αR376D mutants are showing 
60% inhibition whereas αD350R/αR376D, αG351R are showing 20% inhibition. All the mutants 
show residual activity. So, in order to see whether NBD-Cl is completely inhibiting the ATP 
synthase enzyme or not, an extra pulse of NBD-Cl was added.  
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Figure 4: Inhibition of ATPase Activity of Mutants by NBD-Cl.  The membranes were 
preincubated with NBD-Cl for 60 min at RT. The assay was performed as discussed in 
“Materials and Methods”. The solid circles determine wild type and rectangles represent 
mutants.(Continued on the next page) 
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Figure 4: Inhibition of ATPase Activity of Mutants by NBD-Cl.  The membranes were 
preincubated with NBD-Cl for 60 min at RT. The assay was performed as discussed in 
“Materials and Methods”. The solid circles determine wild type and rectangles represent 
mutants. 
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Extra Pulse of NBD-Cl 
 The inhibition with the extra pulse of NBD-Cl was very low. This experiment shows that 
the NBD-Cl reacts particularly at βE catalytic sites and inhibits the reaction completely. Extra 
Pulse of NBD-Cl is shown in Figure 5. An extra pulse retained the residual activity.  
 
Figure 5: Results of Extra Pulse of NBD-Cl in Mutants: The membranes were incubated for 
60min with 150µM NBD-Cl and an extra pulse of 200µM NBD-Cl was added and incubated for 
another 60min. ATPase assay was performed as described in “Materials and Methods”. Each set 
of bars from represent WT, wild type; 1, αD350R; 2, αD350Q; 3, αD350A; 4, αR376A; 5, 
αG351R; 6, αR376D; 7, αD350R/αR376A; 8, αD350R/αR376D; 9, αG351R/αR376A;10, 
αG351R/αR376A from left to right. The %Relative specific activities of the membranes are: 
Wild type (100, 2.6, 2.1); αD350R (100, 22.6, 17.9); αD350Q ( 100,1.4,1.5); αD350A 
(100,37,22); αR376A (100,38,30); αG351R (100,50,35); αR376D (100,19,10);  
αD350R/αR376A (100,6,5); αD350R/αR376D (100,56,48); αG351R/αR376A (100,41,31); 
αG351R/αR376A (100,39,35). 
 
Reversal of ATPase Activity by DTT 
DTT assay was performed to see whether the reaction can be completely reversed or not. 
This assay is an indicative of specificity of reaction. NBD-adduct can be released from βTyr-297, 
after incubating with DTT [30, 31]. The ATPase activity can be completely regained upon 
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addition with DTT. The reversal of ATPase activity upon addition with DTT is shown in Figure 
6. 
 
 
 
Figure 6: Reversal of ATPase Activity by DTT: Membranes were incubated with NBD-Cl for 60 
min, 4mM DTT was added and incubated again for another 60 min. ATPase assay was 
performed as discussed in “Materials and Methods”. Each set of bars on the top figure represent 
Wild type; psr1, αD350R; psr2, αD350Q; psr3, αD350A from left to right. Each set of bars in the 
bottom figure represent Wild type; psr4,αR376A; psr5,αG351R; psr6,αR376D from left to 
right.(Continued on the next page) 
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Figure 6: Reversal of ATPase Activity by DTT: Membranes were incubated with NBD-Cl for 60 
min, 4mM DTT was added and incubated again for another 60 min. ATPase assay was 
performed as discussed in “Materials and Methods”. Each set of bars represent Wild type; psr7, 
αD350R/αR376A; psr8, αD350R/αR376D; psr9, αG351R/αR376A; psr10,αG351R/αR376D; 
from left to right in each group. 
 
Protection Against NBD-Cl Reaction by MgADP 
 MgADP protected purified F1 and F1Fo in membrane from reaction with NBD-Cl, but 
only at extremely high concentration that would effectively keep the third site (βE) occupied in 
time average and thus impede access by NBD-Cl by closing the site [17]. MgADP protection 
against NBD-Cl inhibition of wild type and mutants is shown in Figure 7.  
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Figure 7: (Continued on the next page) 
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Figure 7: Protection Against NBD-Cl Reaction by MgADP: Wild type and mutant membranes 
were preincubated for 60 min at RT with varied concentrations of MgADP, then150µM of NBD-
Cl was added, and incubation continued at RT in the dark for 60 min. The aliquots were then 
assayed for ATPase Activity. 
 
Protection by Pi Against NBD-Cl Inhibition 
Pi protection against NBD-Cl inhibition of wild type and mutants is shown in Figure 8. Pi 
protected well against NBD-Cl inhibition of ATPase activity in wild type as well as αD350Q, 
αD350R, αD350A, αG351R, αR376D, αG351R/αR376A. αD350Q, αD350R, αD350A, αG351R, 
αR376D, αG351R/αR376A regained Pi binding activity and the introduction of arginine at 
αG351R compensated the loss of arginine at α376 position. 
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Figure 8: Protection Against NBD-Cl by Pi: Membranes were preincubated with Pi at 0, 2.5, 5, 
and 10mM concentration as shown, for 60 min at RT. Then NBD-Cl (150µM) was added and 
aliquots were withdrawn for assay at time intervals. ATPase activity remaining is plotted against 
time of incubation with NBD-Cl. (Continued on the next page) 
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Figure 8: Protection Against NBD-Cl by Pi: Membranes were preincubated with Pi at 0, 2.5,5, 
and 10mM concentration as shown, for 60 min at RT. Then NBD-Cl (150µM) was added and 
aliquots were withdrawn for assay at time intervals. ATPase activity remaining is plotted against 
time of incubation with NBD-Cl. (Continued on the next page) 
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Figure 8: Protection Against NBD-Cl by Pi: Membranes were preincubated with Pi at 0, 2.5, 
5and 10mM concentration as shown, for 60 min at RT. Then NBD-Cl (150µM) was added and 
aliquots are withdrawn for assay at time intervals. ATPase activity remaining is plotted against 
time of incubation with NBD-Cl. 
 
Inhibition of ATPase Activity by Fluoroaluminate and Fluoroscandium 
 Inhibition of ATPase activity by transition state analogs is shown in Figure 9. Wild type 
was strongly inhibited (~>95%) and αD350Q was also strongly inhibited. αR376A was inhibited 
by 40%, αR376D by 80%, αD350R by 80%, αD350A by 60%, and αG351R by 60%. The 
introduction of Arginine in αD350R/αR376A resulted in 80% inhibition and αG351R/αR376A 
and αG351R/αR376D resulted in 40% inhibition. The inhibition of Wild type with 
fluoroscandium is >98%, αD350Q, αD350R/αR376A by 80%, αG351R by 30%, αR376D by 
60%, αD350A by 40%, αD350R/αR376D by 20%, αG351R/αR376D by 10%, and 
αG351R/αR376A by 30%. 
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Figure 9: Inhibition of ATPase Activity by Transition State Analogs: The membranes were 
preincubated for 60 min at room temperature with 1mM MgADP, 10mM NaF, and the indicated 
concentrations of AlCl3 or ScCl3.Then aliquots were added to 1 ml of assay buffer, and ATPase 
activity was determined. (Continued on the next page) 
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Figure 9: Inhibition of ATPase Activity by Transition State Analogs: The membranes were 
preincubated for 60 min at room temperature with 1mM MgADP, 10mM NaF, and the indicated 
concentrations of AlCl3 or ScCl3.Then aliquots were added to 1 ml of assay buffer, and ATPase 
activity was determined.  
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CHAPTER 4 
 
DISCUSSION 
 
ATP synthase is one of the smallest known biological nanomotors. ATP synthase exists 
in the body, interacting with any number of proteins and other molecules at any given time, so 
why not use this enzyme as a base model to develop a tiny machine that can go inside our bodies 
to perform various types of work?  
Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical 
interventions on the molecular scale for curing disease or repairing damaged tissues [40]. 
Unclogging arteries, fighting infections, or helping to monitor body systems are a few things 
nanomachines might be capable of. But once a nanomachine is inside the body, how big can it 
be? How fast can it work? Can we alter its speed? How many can we have to perform efficiently 
without disrupting homeostasis? These questions must be addressed in order to build 
nanomachines that are compatible with living tissues and can safely operate inside the body [41]. 
Currently, ATP synthase is the smallest known biological nanomotor. Therefore, understanding 
the mechanisms of how this enzyme works and using ATP synthase as a base model may help to 
develop nanomotors for nanomedicine usage.   
ATP synthesis occurs by the phosphorylation of ADP. According to binding change 
mechanism, ADP and phosphate enter the active site where the protein closes up around the 
molecules and binds them tightly, thus releasing ATP molecule. This process involves several 
residues and understanding the role of conserved residues in and around catalytic sites is the 
primary goal of the project. Earlier it was found that positively charged residues are functionally 
important for Pi binding in the βE catalytic site of E. coli ATP Synthase [20]. In certain other 
43 
 
cases [32] introduction of negative charge in the Pi binding pocket close to βArg-246 prevented 
Pi binding. This gave us an idea to modulate the sites that are very close to the phosphate binding 
residues and understand the mechanism of phosphate binding. Previously, it was found that αSer-
347 of VISIT-DG sequence was involved in Pi binding. The residues αIle-346, αIle-348 and 
αThr-349 were also modulated to see whether they play an important role in Pi binding or not. 
The α-subunit VISIT-DG sequence residue aspartate (D) is ~2.8A0 from R376 of α-
subunit [Fig 2]. The VISIT-DG sequence was chosen because of its conserved nature in many 
organisms. Here we introduced the mutation αD350R (removal of negative charged side chain 
and addition of positive charge), αD350Q (addition of bulky group), αD350A (removing charge 
and size). Here, we mutated the known phosphate binding residue αArg-376 to alanine (A) and 
tried to see its compensatory effect in αD350R background. We mutated αArg-376 to 
aspartate(D) in which we removed positive charge side chain and added a negative charge  and 
tried to see the repulsive effect in normal background. The αGly-351 is mutated to arginine (R), 
a positive charged side chain to see the effect on Pi binding in normal background. 
 The succinate and limiting glucose assays on the mutants showed partial loss of 
oxidative phosphorylation and ATPase activities were very low when compared to the wild type 
[Table 2].  
NBD-Cl inhibition assay showed that αD350Q was just like wild type whereas αD350R, 
αR376D, and αD350R/ αR376A are showing 80-90% inhibition with 10-20% residual activity 
[Fig 4]. αD350A, αR376A, αG351R/αR376A, αG351R/αR376D showed 60% inhibition 
compared to wild type [Fig 4].This indicates that NBD-Cl still reacted  with βTyr-297 in the 
mutants as in wild type and an extra pulse of NBD-Cl determined that it reacted particularly in 
βE catalytic sites and inhibited the reaction completely [Fig 5]. DTT assay is an indicative of 
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specificity of the reaction. NBD-Cl-adduct can be released from βTyr-297 after incubating with 
DTT [30, 31]. The mutants regained the activity indicating the release of NBD-Cl adducts from 
βTyr-297 [Fig 6].  The rate of inactivation was linearly dependant on NBD-Cl concentration and 
protection occurs at high concentrations of MgADP.  All the mutants regained their phosphate 
binding activity when protected against NBD-Cl by MgADP [Fig 7]. 
Earlier studies established that mutagenesis combined with the use of the Pi protection 
assay against NBD-Cl inhibition, as well as the use of inhibitory analogs, enabled 
characterization of functional role(s) of residues suspected to be involved in Pi binding [36-38]. 
αD350R, αD350Q, αD350A mutants showed Pi binding where as αR376A mutant abrogated Pi 
binding in presence of wild type because of the loss of positive side chain of arginine residue 
[Fig 8]. Similarly, αG351R didn’t show any Pi binding in presence of αR376D. However the 
introduction of arginine at α350 position compensated the loss of arginine at α376 position and 
regained the Pi binding activity. However, αD350R/αR376D showed partial gain in Pi binding 
[Fig 8]. The reasons for this might be the effect of charge and introduction of bulky groups. The 
growth on succinate and ATPase activities also supported the Pi protection assays.  
Fluoroaluminate and fluoroscandium in combination with MgADP potently inhibit wild 
type E. coli ATP synthase [20-21, 36-37] and both are believed to mimic the chemical transition 
state. Transition state-like structures involving bound MgADP-AlF4- complex have been seen in 
catalytic sites in ATP synthase by x-ray crystallography [21]. It was observed from the 
fluoroaluminate and fluoroscandium experiments that there is a de-stabilization in transition state 
in αR376A, αG351R, αG351R/αR376D and αG351R/αR376A which was supported by Pi 
binding experiments [Fig 9]. The partial transition state stabilization is seen in the rest of the 
mutants, which is in agreement with Pi binding and oxidative phosphorylation. This shows that 
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there is a functional impairment in all the mutants. There is no loss of transition state 
stabilization in αD350Q that acts similar to wild type [Fig 9] .This may be due to the bulky 
nature of the amino group and its role in catalysis might be indirect.  
From the results, we can conclude that the introduction of positive charged residue 
arginine (R) at αD350 position resulted in the catalysis of ATP synthase and thus played an 
important role in Pi binding, whereas the introduction of alanine (A) in αD350 is involved in 
partial transition state stabilization. The αD350Q mutant was inhibited completely by NBD-Cl 
and regaining the Pi binding activity just like the wild type. It also showed loss of transition state 
stabilization indicating that the introduction of a bulky group doesn’t have any effect in Pi 
binding. The mutant αR376A abrogated the Pi binding and showed a destabilized transition state 
in fluoroaluminate and fluoroscandium experiments. This shows that αR376 is an important Pi 
binging residue that was already known [22]. The introduction of arginine in αD350 
compensated the loss of arginine at α376 (αR376A) position. NBD-Cl showed 80-90% 
inhibition, Pi binding was completely regained and transition state stabilization was seen. This 
indicates that the introduction of positive charge in αD350 position compensated the loss of 
arginine at α376 .Thus, we can say that αD350R/αR376A plays an important role in Pi binding. 
The mutant αD350R/αR376D didn’t show much difference in Pi binding and also in 
transition state stabilization. The mutant’s αG351R, αG351R/αR376A/D didn’t show any 
significant difference. They showed partial inhibition with NBD-Cl and partial transition state 
stabilization by fluoroaluminate and fluoroscandium experiments. This indicates that αG351 may 
not be involved in Pi binding but may be involved in structural integrity of the ATP synthase. 
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Thus, we can accept the hypotheses that αD350 may be involved in Pi binding directly 
and is functionally important residue for maintaining structural integrity. This hypothesis was 
even supported by the compensatory effect of αD350.  However, αG351 may not be involved in 
Pi binding directly but may be involved in structural integrity.  
In the future, in order to confirm that αD350 plays an important role in Pi binding 
directly, we need to perform X-Ray crystal studies and determine the role played by the residues. 
The results shown were only from one set of membranes. So, in order to confirm the effect of 
mutations, assays need to be performed with another set of membranes. The effect of mutations 
on folding has to be determined through fluorescence studies. 
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APPENDICES 
 
APPENDIX A- Abbreviations 
VISIT-DG- Valine-Isoleucine-Serine-Isoleucine-Threonine-Aspartate-Glutamate 
ATP- Adenosine triphosphate 
ADP- Adenosine diphosphate 
Arg [R]- Arginine 
Lys [L]- Lysine 
Ser [S]- Serine 
Gly [G]- Glycine 
Asp [D]- Aspartate 
Ala [A]- Alanine 
Tyr- Tyrosine 
AMP-PNP- Adenylyl imidodiphosphate 
βTP- β triphosphate 
βDP- β diphosphate 
βE-  β empty 
NBD-Cl- 4-chloro-7-nitrobenzofurazan 
MgADP- Magnesium adenosine diphosphate 
AlF4-- Fluoroaluminate 
TRIZMA- Tris [Hydroxyethyl] ethane 
PAB- 4-aminobenzamidine 
SDS- Sodium dodecyl sulphate 
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IPTG- Isopropyl-β-D-1- thio-galactopyranoside 
X-Gal- 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside 
DTT-Dithiothreitol 
NaF- Sodium fluoride 
Alcl3- Aluminum Chloride 
Sncl3- Scandium Chloride 
T&S- Taussky and Shorr 
O.D- Optical density 
ATPcktl- ATP cocktail 
Mbr- Membrane 
Inc-Incubate 
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APPENDIX B- Buffers and Reagents 
50 mM Tris-SO4 buffer 
To 90 ml H2O add 
0.61 g Tris 
Adjust pH to 8.0 with H2SO4 
Bring to a final volume of 100 ml with H2O 
ATPase cocktail 
In 150 ml H2O add 
10 ml 1 M Tris 
0.8 ml 1M MgCl2 
5 ml 0.4 Na ATP (Adenosine 5̍-triphosphate disodium salt) 
Adjust pH to 8.5 with H2SO4 
Bring to a final volume of 200 ml with H2O 
Freeze in plastic bottles at -20°C 
10 % SDS 
100 gm Sodium dodecyl sulfate 
Bring to a final volume of 1000 ml with H2O 
T & S reagent / Taussky and Shorr reagent 
Sol A: 1.2 g Ammonium molybdate ((NH4)6Mo7O24·4H2O in 9.8 ml 12 N H2SO4) 
Sol B: 10 g Ferrous ammonium sulfate (Fe(NH4)2(SO4)2·6H2O in 70 ml H2O) 
Add sol A to sol B while stirring 
Bring to a final volume of 100 ml with H2O 
Store at 4°C 
 
54 
 
STEM 
To 700 ml H2O add 
100 ml 1 M TES 
4.29 g Mg (CH3CO2)2·4H2O 
85.5 g sucrose 
0.0951 g EGTA (Ethylene glycol-bis(2-aminoethylether)-N,N,N,N-tetraacetic acid) 
5 g EACA (6-Ainocaproic acid6-Ainocaproic acid) 
Adjust pH to 6.5 with NaOH 
Bring to a final volume of 1000 ml with H2O 
Freeze in plastic bottles at -20°C 
TES 50 
To 700 ml H2O add 
50 ml 1 M TES 
150 ml glycerol 
5 g EACA (6-Ainocaproic acid6-Ainocaproic acid) 
1 g PAB (4-Aminobenzamidine dihydrochloride) 
Adjust pH to6.5 with NaOH 
Bring to a final volume of 1000 ml with H2O 
Freeze in plastic bottles at -20°C 
TES 5 + PAB 
To 700 ml H2O add 
5 ml 1 M TES 
150 ml glycerol 
1 ml 0.5 M DTT (Dithiothreitol) 
5 g EACA (6-Ainocaproic acid6-Ainocaproic acid) 
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1 g PAB (4-Aminobenzamidine dihydrochloride) 
2.5 ml 0.2 M EDTA (Ethylenediaminetetraacetic acid disodium salt dihydrate) 
Adjust pH to 6.5 with NaOH 
Freeze in plastic bottles at -20°C 
AET (Arginine Ent Thiamine) 
To 60 ml H2O add 
0.617 g 2, 3 dihydroxy benzoic acid 
16.86 g L-Arginine HCl 
1 ml 20 mM Thiamine 
Add just enough amount of NaOH to dissolve everything 
Make final volume to 100 ml with H2O 
Filter sterile and store. 
TE (Trace Elements) 
To 80 ml H2O 
0.251 g Zinc Sulfate (ZnSO4.7H2O) 
0.017 g Manganese Sulfate (MnSO4.H2O) 
0.029 g Boric acid (H3BO3) 
0.012 g Calcium Sulfate (CaSO4.2H2O) 
0.037 g Calcium Chloride (CaCl2.2H2O) 
0.049 g Ferric Chloride (FeCl3.6H2O) 
Make final volume to 100 ml with H2O. 
Filter sterile and store. 
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ILV (Isoleucin-Valine) 
To 95 ml H2O add 
0.394 g Isoleucine 
0.352 g Valine 
Make final volume to 100 ml with H2O 
Filter sterile 
10x Reaction buffer 
100 mM KCl 
100 mM (NH4)2SO4 
200 mM Tris-HCl (pH 8.8) 
20 mM MgSO4 
1% Triton® X-100 
1 mg/ml nuclease-free bovine serum albumin (BSA) 
Cell lysis solution 
0.2M NaOH 
1% SDS 
Cell resuspension solution  
50mM Tris-HCl (pH 7.5) 
10mM EDTA 
100µg/ml RNase A 
Column wash solution 
162.8mM Potassium acetate 
22.6mM Tris-HCl (pH 7.5) 
0.109mM EDTA (pH 8.0) 
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Neutralization solution 
4.09M Guanidine hydrochloride 
0.759M Potassium acetate 
2.12M Glacial acetic acid 
Adjust the final pH to approximately 4.2. 
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APPENDIX C- Culture Media and Plates 
LB liquid medium: 
12.5 g of LB broth powder 
Add H2O to bring to 500 ml 
Autoclave for 30 minutes 
Cool the media to ~50°C 
Add 500 µl of 100 mg/ml Ampicillin 
Minimal Glucose: 
To 400 ml H2O add 
5.225 g Potassium Phosphate Dibasic Trihydrate (K2HPO4) 
2.40 g Sodium Phosphate Monobasic (NaH2PO4) 
0.99 g Ammonium Sulfate ((NH4)2SO4) 
Autoclave for 30 min, cool it and add the following additions 
10 ml Uracil 
10 ml 27 % Glucose 
5 ml ILV (isoleucin-valine) 
0.5 ml TE (trace elements) 
0.5 ml 1 M Magnesium Sulfate (MgSO4) 
0.5 ml AET (Arginine Ent Thiamine) 
0.5 ml 100 mg/ml Ampicillin 
0.312 ml 4X LB 
LB-Agar plate with Ampicillin: 
12.5g of LB broth powder 
7.5g of Agar 
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Bring to a final volume of 500 ml 
Autoclave for 30 minutes 
Cool the media to ~50°C 
Add 500 µl of 100 mg/ml Ampicillin 
Pour into sterile plates 
NZY+ broth: 
To 900 ml of deionized water, add 
10 g of NZ amine (casein hydrolysate) 
5 g of Yeast extract 
5 g of NaCl 
Adjust to pH 7.5 using NaOH and make the final volume to 1 liter. 
Autoclave and add the following filer-sterilized supplements prior to use: 
12.5 ml of 1 M MgCl2 
12.5 ml of 1 M MgSO4 
 and 10 ml of 2M glucose or 20 ml of 20% (w/v) glucose. 
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